Recombinant Human Reg4 Protein, CF
Recombinant Human Reg4 Protein, CF Summary
Asp23-Pro158, with an N-terminal Met
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
|Formulation||Lyophilized from a 0.2 μm filtered solution in PBS.|
|Reconstitution||Reconstitute at 300 - 500 μg/mL in sterile, deionized water.|
|Shipping||The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.|
|Stability & Storage:||Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Reg4 (regenerating islet-derived protein 4), also called Reg IV or RELP (Reg-like protein), is a 17 kDa secreted glycoprotein belonging to the regenerating gene (Reg) family within the calcium (C‑type) dependent lectin superfamily, although carbohydrate binding of Reg4 is calcium-independent (1-4). Human Reg4 is synthesized as a 158 amino acid (aa) precursor with a 22 aa signal sequence and a 136 aa mature chain that contains a C‑type lectin-like domain (CTLD) and one potential N-linked glycosylation site. Human Reg4 shares 68% aa sequence identity with mouse and rat, and 77% with canine and porcine Reg4, respectively. Alternate splicing creates a 134 aa isoform that diverges at aa 56, and a 123 aa isoform that diverges at aa 101 (5). Like other members of the regenerating gene family, Reg4 is preferentially expressed in the gastrointestinal (GI) tract (1, 2, 6). Reg4 expression is increased within or near inflammation, dysplasia and metaplasia of the GI epithelium, such as inflammatory bowel disease (Crohn’s disease and ulcerative colitis), colon adenocarcinoma, pancreatic cancer, gastric adenocarcinoma, and is often increased in the plasma in these conditions (1-3, 6, 7). It is especially associated with neuroendocrine tumors in the GI, as well as some prostate, parathyroid, skin Merkel cell and lung small-cell carcinomas (7-9). Reg4 expression is induced by growth factors and promotes phosphorylation and activation of the EGF R (6, 8, 10). Tumor cells expressing Reg4 are generally more mitogenic, metastatic and resistant to apoptosis (11-13).
- Hartupee, J.C. et al. (2001) Biochim. Biophys. Acta 1518:287.
- Zhang, Y-W. et al. (2003) World J. Gastroenterol. 9:2635.
- Kamarainen, M. et al. (2003) Am. J. Pathol. 163:11.
- Ho, M.R. et al. (2010) J. Mol. Biol. 402:682.
- Protein accession Q9BYZ8-1, Q9BYZ8-2, EAW56711.
- Nanakin, A. et al. (2007) Lab. Invest. 87:304.
- Oue, N. et al. (2005) J. Pathol. 207:185.
- Ohara, S. et al. (2008) Cancer Sci. 99:1570.
- Heiskala, K. et al. (2010) Histol. Histopathol. 25:63.
- Bishnupuri K.S. et al. (2006) Gastroenterology 130:137.
- Rafa, L. et al. (2010) Int. J. Oncol. 36:689.
- Bishnupuri K.S. et al. (2010) Gastroenterology 138:616.
- Guo, Y. et al. (2010) Cancer Genet. Cytogenet. 199:38.
No product specific FAQs exist for this product, however you mayView all Proteins and Enzyme FAQs
Reviews for Recombinant Human Reg4 Protein, CF
Average Rating: 5 (Based on 1 Review)
Have you used Recombinant Human Reg4 Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image